McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1062.16−22.27 (-2.05%)
Close on Nov 19, 2026Market cap $123.84BP/E 28.4Yield 0.30%
McKesson free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
McKesson's free cash flow for the twelve months ending Jun 30, 2026 was $6.42B, up 6.8% year over year. For fiscal 2026 it was $5.72B, up 3.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $5.72B in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $5.72B | +3.1% |
| FY2025 | Mar 31, 2025 | $5.55B | +42.9% |
| FY2024 | Mar 31, 2024 | $3.88B | -18.6% |
| FY2023 | Mar 31, 2023 | $4.77B | +17.9% |
| FY2022 | Mar 31, 2022 | $4.05B | -1.1% |
| FY2021 | Mar 31, 2021 | $4.09B | +2.0% |
| FY2020 | Mar 31, 2020 | $4.01B | +11.1% |
| FY2019 | Mar 31, 2019 | $3.61B | -8.4% |
| FY2018 | Mar 31, 2018 | $3.94B | -9.2% |
| FY2017 | Mar 31, 2017 | $4.34B | +36.3% |
| FY2016 | Mar 31, 2016 | $3.18B | +16.4% |
| FY2015 | Mar 31, 2015 | $2.74B | -4.3% |
| FY2014 | Mar 31, 2014 | $2.86B | +27.5% |
| FY2013 | Mar 31, 2013 | $2.24B | -17.8% |
| FY2012 | Mar 31, 2012 | $2.73B | +29.6% |
| FY2011 | Mar 31, 2011 | $2.11B | -0.6% |
| FY2010 | Mar 31, 2010 | $2.12B | +83.1% |
| FY2009 | Mar 31, 2009 | $1.16B | +71.5% |
| FY2008 | Mar 31, 2008 | $674.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$332.00M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $3.31B | -56.3% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.12B | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $2.31B | +17.8% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.03B | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $7.58B | +91.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$2.51B | -1629.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $1.96B | +120.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.49B | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.96B | +23.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $164.00M | -89.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $890.00M | -12.8% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$1.13B | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.20B | +16.3% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.56B | +19.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $1.02B | -39.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.01B | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $2.75B | -14.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $1.31B | +19.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $1.70B | +84.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$1.72B | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $3.21B | -29.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.09B | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $919.00M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$1.13B | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $4.53B | +20.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$237.00M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$147.00M | -111.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$138.00M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $3.78B | +30.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$308.00M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $1.30B | +155.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.16B | -274.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $2.89B | +126.2% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$123.00M | -143.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $509.00M | -48.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $666.00M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.28B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $286.00M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $994.00M | – |
See a number that looks wrong?